Literature DB >> 18820912

Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?

Albert Altès1, Vanessa Bach, Angels Ruiz, Anna Esteve, Angel F Remacha, M Pilar Sardà, Jordi Felez, Montserrat Baiget.   

Abstract

Most hereditary haemochromatosis patients are homozygous for the C282Y mutation of the HFE gene. However, the phenotypic expression and clinical aggressiveness of the disease differs considerably from patient to patient. The main objective of this work was to study the role of variants in the SLC40A1 gene in the severity of iron overload and his clinical consequences in 100 Spanish probands homozygous for the C282Y mutation of the HFE gene. We performed automated sequencing of the coding regions, including intron-exon junctions of the SLC40A1 gene. We studied the association between polymorphisms in the SLC40A1 gene and median values of iron removed, taking into account statistical corrections for multiple comparisons. No pathogenic mutations in the SLC40A1 were detected. Five known single nucleotide polymorphisms (SNPs) were identified, and two of them were associated with phenotypic characteristics. IVS1-24 C>G was associated with the amount of iron removed and presence of liver disease: Of the 83 patients finally studied for this SNP, the amount of iron removed was above the median in 36 of 56 (64.3%) for C/C, in nine of 23(39.1%) for C/G and in zero of four (0%) for G/G patients (P=0.01). Liver damage was observed in 34 of 56 patients (60.7%) for C/C, in eight of 23 (34.8%) for C/G and in zero of four (0%) for G/G (P=0.01). Both associations remained significant at multivariate analysis (P=0.011 and P=0.023, respectively). IVS1-24 C>G on the ferroportin gene seems to be a genetic modifier for clinical aggressiveness of HFE1 haemochromatosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820912     DOI: 10.1007/s00277-008-0590-9

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  5 in total

1.  The global burden of iron overload.

Authors:  Marnie J Wood; Richard Skoien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2009-07-29       Impact factor: 6.047

Review 2.  Genetic variants in candidate genes influencing NAFLD progression.

Authors:  Michelino Di Rosa; Lucia Malaguarnera
Journal:  J Mol Med (Berl)       Date:  2011-09-06       Impact factor: 4.599

3.  Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.

Authors:  Veronica Tisato; Giovanni Zuliani; Marco Vigliano; Giovanna Longo; Eugenia Franchini; Paola Secchiero; Giorgio Zauli; Elvezia Maria Paraboschi; Ajay Vikram Singh; Maria Luisa Serino; Beatrice Ortolani; Amedeo Zurlo; Cristina Bosi; Antonio Greco; Davide Seripa; Rosanna Asselta; Donato Gemmati
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

4.  Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.

Authors:  Donato Gemmati; Giulia Zeri; Elisa Orioli; Francesca E De Gaetano; Fabrizio Salvi; Ilaria Bartolomei; Sandra D'Alfonso; Claudia Dall'osso; Maurizio A Leone; Ajay V Singh; Rosanna Asselta; Paolo Zamboni
Journal:  BMC Med Genet       Date:  2012-08-10       Impact factor: 2.103

Review 5.  Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.

Authors:  L Tom Vlasveld; Roel Janssen; Edouard Bardou-Jacquet; Hanka Venselaar; Houda Hamdi-Roze; Hal Drakesmith; Dorine W Swinkels
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.